In a field where men have historically been treated as the default and female aspects have been under-researched and under-funded, it’s no surprise that postpartum depression, which happens to 1 in 7 women, hasn’t been treatable with a simple pill—until now. Progress happens. #FeministFriday #GenderEquality #PostpartumDepression #PPD #zuranolone #zurzuvae #MedicalResearch #research

First FDA Approved Oral Drug For Postpartum Depression: The oral neuronsteroid drug zuranolone, branded by Sage Therapeutics/Biogen as Zurzuvae works rapidly and is safe except it precludes breastfeeding. #postpartum #depression #zuranolone #Zurzuvae #breastfeeding
https://www.instagram.com/p/Cy_f7hvRw2w/

With new postpartum depression pill, Big Pharma seem to be finally listening to the female half of the population. https://www.japantimes.co.jp/commentary/2023/08/09/world/postpartum-depression-pill/?utm_content=buffer0f506&utm_medium=social&utm_source=mastodon&utm_campaign=bffmstdn #commentary #worldnews #zuranolone #health #zurzuvae #pregnancy #parenthood #pharmaceuticals #women039sissues #depression #mentalhealth

FDA Approves Zurzuvae (Zuranolone) – First Oral Treatment for Postpartum Depression
The FDA has approved Zurzuvae, a novel oral treatment for postpartum depression. Clinical studies have confirmed its effectiveness, but warnings include potential driving impairment and common side effects. This medication offers a new option beyond the previously available IV treatments.
https://scitechdaily.com/fda-approves-zurzuvae-zuranolone-first-oral-treatment-for-postpartum-depression/ #postpartum #depression #FDA #zurzuvae #oral #treatment

Zurzuvae ofrece una nueva esperanza para las mujeres que luchan contra la depresión posparto
https://bit.ly/3DKoqXv
#FDA #Zurzuvae #depresiónposparto #zuranolona